Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Charting has its place but the skill is in the interpretation of the right ones…. I have only an amateurish exposure, but in todays digital world a whole host of experts, models, trend analysis, interdependencies etc are touted as indicative of forward SP direction. Take a view and make your call…. Plenty of hot air around, some good insights to consider as data points.
CBX are (as usual) vague…. Feb is the placeholder but I’ve also red Q1…. It’s one of their Achilles heels….. communication clarity.
AM01, at last…. Great to see they are starting to try to leverage their product and ride good news.
It’s risk v reward and indeed, CBX is an educated gamble for me….. But I think there are handles and choice points to prevent a total loss, I’d hope most on this BB were sensible enough not to lose everything.
The Company is a start up, finding their feet, have made mistakes, but seem to have a product that could be well received if marketed correctly. My money stays on this horse for a few months longer at least….
IF this indeed helps, I’d really want the board to shout it from the rooftops (assuming it’s peer reviewed and validated) and not be quiet…. Even if it’s prelim data and plays on the fringes of CBX’s offering, they should be capable of framing a positive story.
Come on CEO, let’s have a bit of you and your vision in the open.
CBX is a quality product and is aimed at a premium sector, it’s no where near a bargain bin candidate. The early products have in general positive response which is great, Feb needs to build on this and further establish their brand and niche.
I’m expecting them to deliver still (IMHO).
Not gonna happen just yet….. The company needs to get sales going and establish themselves first, they are way off this in my view.
Forward planning is always essential and I expect they have considered this and other sectors, but first things first.
Windows, I remember an article I read which looked at Gross margins of some cannabinoid Companies (albeit not just lab based products), they were also mainly US and Canada based… Bottom line was (if I recall) an average of 30%…. I expect CBX will be at least this.
I agree the wording is poorly framed and very amateurish… The rabbit can still be pulled out the hat, but only IF they meet the February date…. This would fall into the mix of both statements.
The nervous and easily influenced will react too quickly, both buy and sell…. I think it’s ok to just expect clarity and delivery to be in line with prior commitments ( unless issues are openly and proactively addressed and clearly explained as to why any change occurs).
Feb was clearly mention, now it’s a little vague…. Why do that?
As mentioned a month or so back…. The Marketing Director (IMHO) was way out of his depth.
Good the CEO has stepped in, timing of course isn’t great, but no train smash.
I’m excited too based on all the comments, let’s see what the short term response from the market is…. Looking at the messages one would think positive right? I hope so,and what a start to 2022… Just would prefer a small peak and then a new level established prior to Q2… Too much to hope for?
One would expect the markets to react\acknowledge this then?
I invested before I got a taste of their marketing skills…. I expect it will get better.
I like the product, I have bought, tried and think they are reasonably priced…. But the LinkedIn graphic of the capsules, spray and drops with a red/white background and snowflakes in the foreground is just shocking. I don’t profess to be an expert at marketing or graphic design, but I certainly wouldn’t allow this into the general public. Tosh
I don’t do Facebook, twitter, instagram etc., but I keep a profile on LinkedIn….. I’m starting to see adverts and seasons greetings come up from CBX…. I’m one of the 988 followers…. Hmmmm
Anyway, in what I see, how cheap and tacky the graphics make the product look… if anyone from CBX is reading this, PLEASE STOP and think what you are doing.
I expect it depends….. The A class shares normally attract a 15% withholding tax, most class B shares are taxed via a self assessment tax return (assuming nit in a tax free wrapper).
The main reason AA got pushed aside, he demonstrated limited ability to execute…. The Board should also take some blame….. But at least they pulled in a new CEO well ahead of the investment community realising the gaps.
Some may say the soft launch was a test of the water in terms of execution, fair comment perhaps, but the first impression window has gone, the saving grace is the marketing was so light CBX are still pretty much anonymous to the general public and their targeted audience. This helps with the second bite of the cherry on execution…. Feb will define them to a fair extent, I don’t think all is lost, the Company can still shine.
Lol….. auto correct….. precedent not president!
Retain the choice but accept the consequences and specific personal contributions to health care cost is reasonable in my view. I’m with bald-eagle, and whilst the examples given on smoking, junk food etc are valid, they are not a president in this case.